Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
34,309,263
-
Total 13F shares
-
9,292,336
-
Share change
-
-6,577
-
Total reported value
-
$60,284,402
-
Price per share
-
$6.48
-
Number of holders
-
25
-
Value change
-
-$39,068
-
Number of buys
-
12
-
Number of sells
-
9
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q4 2019
As of 31 Dec 2019,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,292,336 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Avoro Capital Advisors LLC, Solas Capital Management, LLC, 683 Capital Management, LLC, Sonic Fund II, L.P., EVENTIDE ASSET MANAGEMENT, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, OXFORD ASSET MANAGEMENT LLP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Hartford Financial Management Inc..
This page lists
26
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.